August 27, 2025
According to a study published by Cyclarity Therapeutics, its drug UDP-003 shows benefits in reversing the root cause of atherosclerotic plaques [1]. Fighting the root cause Many available medications address only disease symptoms in an effort to mitigate them. However, the real challenge is to identify the root cause of a problem and find ways...